Advertisement

Comparison of Indomethacin and Ibuprofen

  • Bart van Overmeire

Keywords

Preterm Infant Patent Ductus Arteriosus Adverse Renal Effect Ductal Closure Acute Pulmonary Hypertension 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. 1.
    Adams SS, Bresloff P, Mason CG. Pharmacological differences between the optical isomers of ibuprofen: Evidence for metabolic inversion of the (-)-isomer. J Pharm Pharmacol 1976; 28:256–7.PubMedGoogle Scholar
  2. 2.
    Heyman E, Morag I, Batash D, Keidar R, Baram S, Berkovitch M. Closure of patent ductus arteriosus with oral ibuprofen suspension in premature newborns: A pilot study. Pediatrics 2003; 112:e354–8.CrossRefPubMedGoogle Scholar
  3. 3.
    Patel J, Marks KA, Roberts I, Azzopardi D, Edwards AD. Ibuprofen treatment of patent ductus arteriosus. Lancet 1995; 346:255.PubMedGoogle Scholar
  4. 4.
    Varvarigou A, Bardin CL, Beharry K, Chemtob S, Papageorgiou A, Aranda JV. Early ibuprofen administration to prevent patent ductus arteriosus in premature newborn infants. JAMA 1996; 275:539–44.CrossRefPubMedGoogle Scholar
  5. 5.
    Van Overmeire B, Follens I, Hartmann S, Creten WL, Van Acker KJ. Treatment of patent ductus arteriosus with ibuprofen. Arch Dis Child 1997; 76:F179–84.Google Scholar
  6. 6.
    Van Overmeire B, Smets K, Lecoutere D, Van de Broek H, Weyler J, De Groote K, Langhendries J-P. A comparison of ibuprofen and indomethacin for closure of patent ductus arteriosus. N Engl J Med 2000; 343:674–81.CrossRefPubMedGoogle Scholar
  7. 7.
    Ohlsson A, Walia R, Shah S. Ibuprofen for the treatment of a patent ductus arteriosus in preterm and/or low birth weight infants (Cochrane Review). The Cochrane Library 2003; Issue 2, Oxford.Google Scholar
  8. 8.
    Shah SS, Ohlsson A. Ibuprofen for the prevention of patent ductus arteriosus in preterm and/or low birth weight infants (Cochrane Review). The Cochrane Library 2003; Issue 2, Oxford.Google Scholar
  9. 9.
    Gournay V, Savagner C, Thiriez G, Kuster A, Rozé J-C. Pulmonary hypertension after ibuprofen prophylaxis in very preterm infants. Lancet 2002; 359: 1486–8.CrossRefPubMedGoogle Scholar
  10. 10.
    Schmidt B, Wright LL, Davis P, Solimano A, Roberts RS. Ibuprofen prophylaxis in preterm neonates. Lancet 2002; 360: 492.PubMedGoogle Scholar
  11. 11.
    Van Overmeire B, Casaer A, Allegaert K, Debauche C, Decaluwe W, Jespers A, Weyler J, Langhendries JP. Multicenter randomized double-blind placebo controlled trial of ibuprofen prophylaxis in very preterm infants. Pediatr Res 2002; 51: 379A.Google Scholar
  12. 12.
    Fowlie PW, Davis PG. Prophylactic intravenous indomethacin for preventing mortality and morbidity in preterm infants (Cochrane Review). The Cochrane Library 2003; Issue 1 2003. Oxford.Google Scholar
  13. 13.
    Schmidt B, Davis P, Moddemann D, Ohlsson A, Roberts RS, Saigal S, Solimano A, Vincer M, Wright LL, for the Trial of Indomethacin Prophylaxis in Preterms Investigators. Long-term effects of indomethacin prophylaxis in extremely-low-birth-weight infants. N Engl J Med 2001; 344: 1966–72.CrossRefPubMedGoogle Scholar
  14. 14.
    Pezzati M, Vangi V, Biagiotti R, Bertini G, Cianciulli D, Rubaltelli FF. Effects of indomethacin and ibuprofen on mesenteric and renal blood flow in preterm infants with patent ductus arteriosus. J Pediatr 1999; 135: 733–8.PubMedGoogle Scholar
  15. 15.
    Guignard JP. The adverse renal effects of prostaglandin-synthesis inhibitors in the newborn rabbit. Semin Perinatol 2002; 26: 398–405.PubMedGoogle Scholar
  16. 16.
    Mosca F, Bray M, Lattanzio M, Fumagalli M, Tosetto C. Comparative evaluation of the effects of indomethacin and ibuprofen on cerebral perfusion and oxygenation in preterm infants with patent ductus arteriosus. J Pediatr 1997; 131: 549–54.PubMedGoogle Scholar
  17. 17.
    Naulaers G, Delanghe G, Allegaert K, Casaer P, Devlieger H, Van Overmeire B. Randomized double-blind controlled trial comparing the effects of ibuprofen with placebo on cerebral hemodynamics. Pediatr Res 2002; 51: 338A.Google Scholar
  18. 18.
    Van Overmeire B, Touw D, Schepens PJC, Kearns GL, van den Anker JN. Ibuprofen pharmacokinetics in preterm infants with patent ductus arteriosus. Clin Pharmacol Ther 2001; 70: 336–43.PubMedGoogle Scholar
  19. 19.
    Cooper-Peel C, Brodersen R, Robertson A. Does ibuprofen affect bilirubin-albumin binding in newborn infant serum?. Pharmacol Toxicol 1996; 79: 297–9.PubMedCrossRefGoogle Scholar
  20. 20.
    Ahlfors CE. Effect of ibuprofen on bilirubin-albumin binding. J Pediatr 2004; 144: 386–8.PubMedGoogle Scholar
  21. 21.
    Su, PH, Chen JY, Su CM, Huang TC, Lee HS. Comparison of ibuprofen and indomethacin therapy for patent ductus arteriosus in preterm infants. Pediatr Int 2003; 45: 665–70.CrossRefPubMedGoogle Scholar
  22. 22.
    Gregoire N, Gualano V, Geneteau A, Millerioux L, Brault M, Mignot A, Roze JC. Population pharmacokinetics of ibuprofen enantiomers in very premature naonates. J Clin Pharmacol 2004; 44: 1114–24.PubMedGoogle Scholar

Copyright information

© Springer Medizin Verlag Heidelberg 2005

Authors and Affiliations

  • Bart van Overmeire
    • 1
  1. 1.Department of Pediatrics, Division of NeonatologyUniversity Hospital of AntwerpEdegemBelgium

Personalised recommendations